¼¼°èÀÇ ¶õ¼Â ½ÃÀå
Lancets
»óǰÄÚµå : 1768136
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 375 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,225,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,675,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ ¶õ¼Â ½ÃÀåÀº 2030³â±îÁö 66¾ï ´Þ·¯¿¡ À̸¦ Àü¸Á

2024³â¿¡ 47¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ¶õ¼Â ¼¼°è ½ÃÀåÀº 2024-2030³â CAGR 5.7%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 66¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. º» º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ ¾ÈÀü ¶õ¼ÂÀº CAGR 5.6%¸¦ ³ªÅ¸³»°í, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 28¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. Ç¥ÁØ ¶õ¼ÂÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£Áß CAGR 3.8%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 12¾ï ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 9.2%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ¶õ¼Â ½ÃÀåÀº 2024³â¿¡ 12¾ï ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 16¾ï ´Þ·¯ ±Ô¸ð¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGRÀº 9.2%·Î ÃßÁ¤µË´Ï´Ù. ±âŸ ÁÖ¸ñÇØ¾ß ÇÒ Áö¿ªº° ½ÃÀåÀ¸·Î¼­´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£Áß CAGRÀº °¢°¢ 3.0%¿Í 4.4%¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 3.8%¸¦ ³ªÅ¸³¾ Àü¸ÁÀÔ´Ï´Ù.

¼¼°èÀÇ ¶õ¼Â ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

·£½ËÀº Ç÷¾× »ùÇøµ°ú ȯÀÚ Ä¡·á¿¡ ¾î¶² Çõ¸íÀ» ÀÏÀ¸Å°°í Àִ°¡?

¶õ¼ÂÀº °Ë»ç¿ë Ç÷¾× »ùÇÃÀ» äÃëÇϱâ À§ÇÑ ¼ÒÇü ÀÇ·á±â±â·Î, Á¤±âÀûÀÎ Ç÷´ç ¸ð´ÏÅ͸µÀÌ ÇÊ¿äÇÑ ´ç´¢º´°ú °°Àº Áúȯ °ü¸®¿¡ ÇʼöÀûÀÎ ÀÇ·á±â±âÀÔ´Ï´Ù. ¶õ¼ÂÀº ÇǺθ¦ ºü¸£°Ô, ÃÖ¼Ò Ä§½ÀÀûÀ¸·Î õÀÚÇÏ¿© ¸ð¼¼Ç÷°üÀÇ Ç÷¾×À» äÃëÇÒ ¼ö ÀÖµµ·Ï ¼³°èµÇ¾î ÀÖ½À´Ï´Ù. ¼ö³â µ¿¾È ¾ÈÀüÇÑ ¶õ¼Â°ú ÀÏȸ¿ë ±â±âÀÇ °³¹ß·Î äÇ÷¿¡ Çõ¸íÀ» ÀÏÀ¸ÄÑ ±³Â÷ ¿À¿°°ú °¨¿°ÀÇ À§ÇèÀ» ÁÙÀÓÀ¸·Î½á ȯÀÚÀÇ ¾ÈÀü¼ºÀ» Çâ»ó½ÃÄ×½À´Ï´Ù. ¶õ¼ÂÀº ÀÓ»ó ÇöÀå°ú ÀçÅà ġ·á ¸ðµÎ¿¡¼­ ³Î¸® »ç¿ëµÇ°í ÀÖÀ¸¸ç, ÀÇ·á¿¡ ¾ø¾î¼­´Â ¾È µÉ Çʼö µµ±¸°¡ µÇ¾ú½À´Ï´Ù.

¶õ¼Â ½ÃÀåÀ» Çü¼ºÇϰí ÀÖ´Â ±â¼ú Çõ½ÅÀº ¹«¾ùÀΰ¡?

¶õ¼ÂÀÇ µðÀÚÀΰú ±â´ÉÀÇ ±â¼úÀû Áøº¸´Â ¾ÈÀü, Æí¾ÈÇÔ, »ç¿ë ÆíÀǼºÀ» Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù. »ç¿ë ÈÄ º¸°üµÇ´Â ¾ÈÀü¼ºÀÌ ³ôÀº ¶õ¼ÂÀº ½Ç¼ö·Î ÀÎÇÑ ¹Ù´Ã¿¡ Âñ¸®´Â »ç°í¸¦ ¹æÁöÇϰí Ç÷¾× °¨¿°ÀÇ À§ÇèÀ» ÁÙÀ̱⠶§¹®¿¡ º´¿øÀ̳ª Áø´Ü ½ÇÇè½Ç°ú °°Àº ´ë·® ÀÇ·á ÇöÀå¿¡¼­ ƯÈ÷ À¯¿ëÇÏ°Ô »ç¿ëµË´Ï´Ù. ¶ÇÇÑ, ±Ø¼¼Ä§ ±â¼úÀÇ ¹ßÀüÀ¸·Î ¶õ¼ÂÀº äÇ÷ ½Ã ÅëÁõÀ» ÃÖ¼ÒÈ­ÇÏ¿© ȯÀڵ鿡°Ô ´õ¿í Æí¾ÈÇÔÀ» ¼±»çÇÕ´Ï´Ù. µðÁöÅÐ Çコ ¹× ¿ø°Ý ¸ð´ÏÅ͸µÀÇ ÀαⰡ ³ô¾ÆÁö¸é¼­ ¶õ¼ÂÀÇ µðÀÚÀÎ Çõ½ÅÀÌ °¡¼ÓÈ­µÇ°í ÀÖÀ¸¸ç, ÇöÀç ÀÌ ÀåÄ¡´Â ¸ð¹ÙÀÏ ¾Û°ú µ¿±âÈ­µÇ´Â Ç÷´ç ¸ð´ÏÅ͸µ ½Ã½ºÅÛ¿¡ ÅëÇյǾî ȯÀÚ°¡ ½Ç½Ã°£À¸·Î µ¥ÀÌÅ͸¦ ÃßÀûÇÒ ¼ö ÀÖµµ·Ï Çϰí ÀÖ½À´Ï´Ù.

½ÃÀå ¼¼ºÐÈ­´Â ¶õ¼ÂÀÇ ¼ºÀåÀ» ¾î¶»°Ô Á¤ÀÇÇϴ°¡?

À¯Çü¿¡´Â ¾ÈÀü ¶õ¼Â, Ç¥ÁØ ¶õ¼Â, Ư¼ö ¶õ¼Â, Àü¹® ¶õ¼ÂÀÌ ÀÖÀ¸¸ç, ¾ÈÀü ¶õ¼ÂÀº °¨¿° °ü¸®¸¦ À§ÇØ º´¿ø ¹× Ŭ¸®´Ð¿¡¼­ ³Î¸® »ç¿ëµÇ¾î °¡Àå Å« ºÎ¹®À» Â÷ÁöÇÕ´Ï´Ù. ÀÀ¿ë ºÐ¾ß¿¡´Â Ç÷´ç °Ë»ç, ÄÝ·¹½ºÅ×·Ñ °Ë»ç, Çì¸ð±Û·Îºó °Ë»ç, ¾Ë·¹¸£±â °Ë»ç µîÀÌ ÀÖÀ¸¸ç, Àü ¼¼°è ´ç´¢º´ À¯º´·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó Ç÷´ç °Ë»ç°¡ ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ÃÖÁ¾ »ç¿ëÀÚ¿¡´Â º´¿ø, Áø·á¼Ò, Áø´Ü ½ÇÇè½Ç, ÀçÅà Áø·á ÇöÀå µîÀÌ Æ÷ÇԵǸç, ´ç´¢º´°ú °°Àº ¸¸¼ºÁúȯÀ» Áý¿¡¼­ °ü¸®Çϴ ȯÀÚ°¡ Áõ°¡ÇÔ¿¡ µû¶ó ÀçÅà Áø·á°¡ Áß¿äÇÑ ¼ºÀå ºÐ¾ß·Î ¶°¿À¸£°í ÀÖ½À´Ï´Ù.

¶õ¼Â ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ¿äÀÎÀº ¹«¾ùÀΰ¡?

¶õ¼Â ½ÃÀåÀÇ ¼ºÀåÀº ´ç´¢º´ À¯º´·ü Áõ°¡, ÀçÅà Ç÷´ç ¸ð´ÏÅ͸µ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ¾ÈÀü ¹× ÆíÀÇ ±â´ÉÀÇ ¹ßÀü µî ¿©·¯ °¡Áö ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. Àü ¼¼°èÀûÀ¸·Î ´ç´¢º´ÀÇ ºÎ´ãÀÌ Áõ°¡ÇÔ¿¡ µû¶ó Á¤±âÀûÀÎ Ç÷¾× °Ë»çÀÇ Çʿ伺ÀÌ ·£½Ë¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖÀ¸¸ç, ƯÈ÷ ȯÀÚ°¡ Æí¸®ÇÏ°í »ç¿ëÇϱ⠽¬¿î ÀåÄ¡¸¦ ÇÊ¿ä·Î ÇÏ´Â ÀçÅà ġ·á ȯ°æ¿¡¼­ ÀÌ·¯ÇÑ °æÇâÀÌ µÎµå·¯Áý´Ï´Ù. °¨¿° À§ÇèÀ» ÁÙÀ̰í ȯÀÚÀÇ Æí¾ÈÇÔÀ» Çâ»ó½ÃŰ´Â ¾ÈÀü ·£½ËÀÇ ±â¼ú Çõ½ÅÀº ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÄÝ·¹½ºÅ×·Ñ, Çì¸ð±Û·Îºó °Ë»ç µî ´Ù¾çÇÑ °Ë»ç¸¦ ¼öÇàÇÏ´Â Áø´Ü ½ÇÇè½Ç¿¡¼­ ·£½ËÀÇ »ç¿ëÀÌ Áõ°¡Çϰí ÀÖ´Â °Íµµ ½ÃÀåÀ» È®´ëÇϰí ÀÖ½À´Ï´Ù.

ºÎ¹®

Á¦Ç° À¯Çü(¾ÈÀü, ½ºÅÄ´Ùµå, ½ºÆä¼ÈƼ), ¿ëµµ(Ç÷´ç °Ë»ç, Çì¸ð±Û·Îºó °Ë»ç, ÄÝ·¹½ºÅ×·Ñ °Ë»ç, ÀÀ°í °Ë»ç, ±âŸ ¿ëµµ), ÃÖÁ¾ ¿ëµµ(º´¿ø ¹× Áø·á¼Ò, ÀçÅÃÄ¡·á, ±âŸ ÃÖÁ¾ ¿ëµµ)

Á¶»ç ´ë»ó ±â¾÷ ¿¹

AI ÅëÇÕ

´ç»ç´Â À¯È¿ÇÑ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AIÅø¿¡ ÀÇÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ º¯ÇõÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â ÀϹÝÀûÀÎ LLM³ª ¾÷°èº° SLM Äõ¸®¿¡ µû¸£´Â ´ë½Å¿¡, ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ´ë·® ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî, Àü ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»çÀÇ ±¹°¡, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±â¹ÝÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¼öÀÍ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº °¨¼Ò, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû ¹× °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Lancets Market to Reach US$6.6 Billion by 2030

The global market for Lancets estimated at US$4.7 Billion in the year 2024, is expected to reach US$6.6 Billion by 2030, growing at a CAGR of 5.7% over the analysis period 2024-2030. Safety, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$2.8 Billion by the end of the analysis period. Growth in the Standard segment is estimated at 3.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.2 Billion While China is Forecast to Grow at 9.2% CAGR

The Lancets market in the U.S. is estimated at US$1.2 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.6 Billion by the year 2030 trailing a CAGR of 9.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.0% and 4.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.8% CAGR.

Global Lancets Market - Key Trends and Drivers Summarized

How Are Lancets Revolutionizing Blood Sampling and Patient Care?

Lancets, small medical devices used to obtain blood samples for testing, are essential in managing conditions such as diabetes, where regular blood glucose monitoring is required. Lancets are designed to make quick and minimally invasive punctures on the skin, allowing for the collection of capillary blood. Over the years, the development of safety lancets and single-use devices has revolutionized blood sampling, improving patient safety by reducing the risk of cross-contamination and infection. Lancets are widely used in both clinical settings and home care, making them an indispensable tool in healthcare.

What Technological Innovations Are Shaping the Lancets Market?

Technological advancements in lancet design and functionality are enhancing their safety, comfort, and ease of use. Safety lancets, which retract after use, prevent accidental needle sticks and reduce the risk of bloodborne infections, making them particularly valuable in high-volume healthcare settings such as hospitals and diagnostic labs. Furthermore, advancements in ultra-thin needle technology have made lancets more comfortable for patients by minimizing pain during blood sampling. The growing popularity of digital health and remote monitoring is also driving innovations in lancet design, with devices now being integrated into blood glucose monitoring systems that sync with mobile apps, allowing patients to track their data in real time.

How Do Market Segments Define the Growth of Lancets?

Types include safety lancets, standard lancets, and specialty lancets, with safety lancets representing the largest segment due to their widespread use in hospitals and clinics for infection control. Applications include blood glucose testing, cholesterol testing, hemoglobin testing, and allergy testing, with blood glucose testing leading the market as the global incidence of diabetes continues to rise. End-users include hospitals, clinics, diagnostic labs, and home care settings, with home care becoming a key growth area as more patients manage chronic conditions like diabetes from the comfort of their homes.

What Factors Are Driving the Growth in the Lancets Market?

The growth in the lancets market is driven by several factors, including the rising prevalence of diabetes, increasing demand for home-based blood glucose monitoring, and advancements in safety and comfort features. As the global burden of diabetes grows, the need for regular blood testing is driving demand for lancets, particularly in home care settings where patients require convenient and easy-to-use devices. Technological innovations in safety lancets, which reduce the risk of infection and improve patient comfort, are further propelling market growth. Additionally, the increasing use of lancets in diagnostic labs for a variety of tests, including cholesterol and hemoglobin testing, is expanding the market.

SCOPE OF STUDY:

The report analyzes the Lancets market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Safety, Standard, Specialty); Application (Blood Glucose Testing, Hemoglobin Testing, Cholesterol Testing, Coagulation Testing, Other Applications); End-Use (Hospitals & Clinics, Home Care, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â